The Impact of New Antibiotic Stewardship Program and Vancomycin Susceptibility Pattern of Group D Enterococci: Experience in the Specialized Neurological Hospital
Keywords:Antibiotic stewardship program, Vancomycin time out, Prior authorization, Group D Enterococci, Specialized Neurological Hospital
Background: The Antibiotic Stewardship Program (ASP) is an important process to reduce rate of drugresistance of pathogens in hospitals. In the past, we used retrospective audit process to monitor antibiotics usage, before providing feedback for specific usage suggestion. We collected broad-spectrum antibiotics usage data through antibiotic request forms and Defined Daily Dose (DDD) records. Recent data from antimicrobial susceptibility pattern report shown that the vancomycin usage significantly increased while the antimicrobial susceptibility pattern of group D enterococci decreased from 100 percent to 96 percent. These undesirable trends could lead to higher rate of drug-resistance of pathogens in our hospital.Objective: To study the alternative ASP intervention that can reduce vancomycin usage and improve antimicrobial susceptibility of group D enterococci to the vancomycin.Method: This study was a descriptive observation study. We collected data from 442 admitted patients who filled the request forms to use vancomycin during January 1st, 2014 to December 31st, 2017. The 215 patients who received vancomycin during 2014-2015 were treated under retrospective audit and feedback (previous ASP). The remaining 227 patients who received vancomycin during 2016-2017 were implemented the antibiotics automatic timeout and pre-authorized intervention (new / alternative ASP). With this new ASP, the vancomycin usage will be automatically stopped after 72 hours of initial use and will require pre-authorization from internal medicine staffs to continue the usage afterward. After that, we evaluated impact of this new ASP by comparing changes of the vancomycin usage and the antimicrobial susceptibility pattern of gram-positive resistant bacteria from microbiological laboratories annual reports.Result: After implementing the new antibiotics automatic timeout and pre-authorized intervention, the DDD decreases from 32.1 per 1,000 inpatient-day in 2014 and 44.5 per 1,000 inpatient-day in 2015 to 34.4 per 1,000 inpatient-day in 2016 and 39.3 per 1,000 inpatient-day in 2017. Meanwhile, the antimicrobial susceptibility of group D enterococci to vancomycin improves from 96 percent in 2014 and 95 percent in 2015 to 100 percent in both 2016 and 2017.Conclusion: This new ASP intervention which combines the vancomycin automatic timeout with pre-authorization (after the timeout) is proven to be more effective method to control vancomycin resistant group D enterococci.
Yesim C, Pamela F and C. Glen M. Vancomycin-resistant enterococci. Clinical Microbiology Reviews 2000;3(4):686-707.
National Antimicrobial Resistance Surveillance Center Thailand [internet]. Antimicrobial Resistance 2000-2019.[cited 2020 Apr 04]. Available from: http://narst.dmsc.moph.go.th/data/AMR%20 2000-2019-06M.pdf.
The European Centre for Disease Prevention and Control [internet]. Surveillance of antimicrobial resistance in Europe 2017. [cited 2020 Apr 04]. Available from: https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobialresistance-europe-2017.
Davey P, Brown E, Fenelon L, Finch R, Gould I, Hartman G, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev 2005;:CD003543.
Tamma PD, Cosgrove SE. Antimicrobial stewardship. Infect Dis Clin North Am 2011;25:245–60.
The Centers for Disease Control and Prevention [internet]. The core elements of hospital antibiotic stewardship programs 2019. [cited 2020 Apr 04]. Available from: https://www.cdc.gov/antibiotic-use/healthcare/pdfs/hospital-core-elements-H.pdf.
Brandl K, Plitas G, Mihu CN, Ubeda C, Jia T, Fleisher M, et al.Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 2008;455:804-7.
Bhavnani SM, Drake JA, Forrest A, Deinhart JA, Jones RN, Biedenbach DJ, et al. A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.Diagn Microbiol Infect Dis 2000;36:145-58.
National antimicrobial resistance surveillance center Thailand [internet]. Antimicrobial Resistance 2000-2019.[cited 2020 Apr 04]. Available from: http://narst.dmsc.moph.go.th/data/AMR%20 2000-2019-06M.pdf.
Centers of disease control and prevention [internet]. Core elements of hospital antibiotic stewardship programs. [cited 2020 May 23]. Available from: https://www.cdc.gov/antibiotic-use/core-elements/hospital.html.
Ibrahim M, Bazzi Z. A retrospective audit of antibiotic prescriptions in a Lebanese Hospital. International Journal of Infection Control 2019;15:1-10.
Chautrakarn S, Anugulruengkitt S, Puthanakit T, Rattananupong T, Hiransuthikul N. Impact of a prospective audit and feedback antimicrobial stewardship program in pediatric units in tertiary care teaching hospital in Thailand. Hosp Pediatr 2019;9:851-8.
Yeo CL, Wu JE, Chung GW, Chan DS, Chen HH, Hsu LY.Antimicrobial stewardship auditing of patients reviewed by infectious diseases physicians in a tertiary university hospital.Antimicrob Resist Infect Control 2013;2:29.
Wirtz AL, Burns AN, Lee BP, Frank TS, Fitzmaurice L, Ogden RK, et al. Effectiveness and safety of mandatory antimicrobial indications and durations and a pharmacist-driven 48-hour time-out in a pediatric hospital. Am J Health Syst Pharm 2020;77:614–21.
Graber CJ, Jones MM, Glassman PA, Weir C, Butler J, Nechodom K, et al. Taking an antibiotic time-out:Utilization and usability of a self-stewardship time-out program for renewal of Vancomycin and Piperacillin-Tazobactam. Hosp Pharm 2015;50:1011–24.
Mehta JM, Haynes K, Wileyto EP, Gerber JS, Timko DR, Morgan SC, et al. Comparison of prior authorization and prospective audit with feedback for antimicrobial stewardship. Infect Control Hosp Epidemiol 2014;35:1092-9.
Chung GW, Wu JE, Yeo CL, Chan D, Hsu LY. Antimicrobial stewardship: a review of prospective audit and feedback systems and an objective evaluation of outcomes. Virulence 2013;4:151-7.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
ข้อความและข้อคิดเห็นต่างๆ เป็นของผู้เขียนบทความ ไม่ใช่ความเห็นของกองบรรณาธิการหรือของวารสารกรมการแพทย์